
November 11, 2026
Oregon Health Authority: Cannabis harms, benefits described in new public health statements: External Relations Division: State of Oregon https://share.google/194mBuRg1hedlyClD
November 5, 2026
OHA revises, expands statements published after Measure 91 passage in 2014
PORTLAND,Ore.—Oregon Health Authority has published updated public health statements offering guidance to clinicians, local public health agencies, legislators and the public on the potential harms and benefits of cannabis use.
Based on extensive review of scientific literature and key reports from around the world, the 2026 Cannabis Public Health Statements expand and revise previous statements an OHA-convened Retail Marijuana Scientific Advisory Committee developed in 2015. The earlier statements, which were updated in 2017, were created following the 2014 passage of Measure 91, which legalized recreational marijuana use, sale, and possession.
Cannabis policy and science has changed considerably since 2017. “We set out to capture as much recent data and evidence as possible, from hundreds of studies and reports, to provide a comprehensive picture of the potential health harms and health benefits of cannabis use,” said Tom Jeanne, M.D., M.P.H., deputy state health officer and epidemiologist at the OHA Public Health Division.
The statements are for educational purposes and are not a substitute for medical care or consultation with a health care professional.
The summary accompanying the statements describes cannabis terminology, cannabis products and potency, how cannabis is consumed, and recommendations for individuals considering cannabis use. The summary also offers guidance on interpreting the public health statements, including cautioning that health outcomes described as “linked to” or having an association with cannabis use or exposure do not prove causation.
The statements’ findings include moderate or strong evidence linking cannabis use and health harms. Those include:
Findings of moderate or strong evidence linking cannabis use and health benefits included:
The summary describes limitations with some of the Cannabis Public Health Statements, noting that “A few health statements are listed that have ‘insufficient evidence’ because they were included in other major reviews or prior Oregon health statements.” The summary also points out that “Due to the evolution of cannabis products, and lack of clarity in the research, actual risks could vary by product type (for example, smoked, edible, or vaporized), and by the amount of THC, CBD, and other ingredients or additives in products.”
In addition, according to summary authors, the review was conducted with a small team of OHA staff with limited resources, and as such, “our approach was not as in depth as a very large review, such as reviews by the Cochrane Collaboration or the National Academies of Sciences, Engineering, and Medicine.”
“Although we aimed to conduct a comprehensive review, these findings should not be taken to be exhaustive and representative of the entire body of cannabis health effects research, which is constantly expanding,” summary authors wrote.